ペルセウスプロテオミクス(4882) – Announcement of Establishment of Voluntary Remuneration Committee

URLをコピーする
URLをコピーしました!

開示日時:2022/04/20 16:00:00

損益

決算期 売上高 営業益 経常益 EPS
2018.03 30,398 -16,618 -16,596 -19.56
2019.03 27,596 -14,481 -14,461 -17.89
2020.03 8,576 -81,240 -82,639 -92.33
2021.03 6,795 -41,175 -41,192

※金額の単位は[万円]

株価

前日終値 50日平均 200日平均 実績PER 予想PER
384.0 410.72 577.7034

※金額の単位は[円]

キャッシュフロー

決算期 フリーCF 営業CF
2018.03 -13,280 -13,236
2019.03 -34,468 -32,966
2020.03 -61,113 -60,852
2021.03 -42,566 -42,284

※金額の単位は[万円]

▼テキスト箇所の抽出

To all stakeholders, April 20, 2022 Perseus Proteomics Inc. Securities Code: 4882 Growth TSE Announcement of Establishment of Voluntary Remuneration Committee Perseus Proteomics Inc. (HQ: Meguro-ku, Tokyo, President & CEO: Takuya Yokokawa) hereby announces that the Company has resolved to establish the voluntary Remuneration Committee at the Board The Remuneration Committee shall be established to enhance independence, objectivity, and accountability of the Board of Directors related to remuneration of Directors who are not audit and The Remuneration Committee shall make reports or proposal to the Board of Directors after examining the policy for determination of remuneration of Directors who are not audit and supervisory committee members, respective remuneration, and others. 3. Members of the Remuneration Committee The Remuneration Committee shall consist of three or more committee members elected by the resolution of the Board of Directors. More than half of the committee members shall be independent of Directors’ Meeting held today. 1. Purpose of the establishment supervisory committee members. 2. Role of the Remuneration Committee outside Directors. 4. Date of establishment April 20, 2022 END 1 / 1

この記事が気に入ったら
いいね または フォローしてね!

シェアしたい方はこちらからどうぞ
URLをコピーする
URLをコピーしました!